SCHEMBL201174

SCHEMBL201174

N#Cc1ccc(OC(F)(F)F)cc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TRPA1 O75762 1/20 0.53
SCN5A Q14524 1/20 0.53
SCN9A Q15858 1/20 0.53
MAPT P10636 3/20 0.47
ALDH1A1 P00352 3/20 0.47
TDP1 Q9NUW8 2/20 0.47
MEN1 O00255 1/20 0.47
TP53 P04637 1/20 0.47
CYP3A4 P08684 1/20 0.47
ALOX15 P16050 1/20 0.47
TSHR P16473 1/20 0.47
BLM P54132 1/20 0.47
KMT2A Q03164 1/20 0.47
SMN1; SMN2 Q16637 1/20 0.47
HIF1A Q16665 1/20 0.47
HSD17B10 Q99714 1/20 0.47
EPAS1 Q99814 1/20 0.47
EPHX2 P34913 2/20 0.47
KIF11 P52732 1/20 0.47
CA2 P00918 2/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2803766 0.94 KIF11 (0.57) TRPA1SCN5ASCN9AMAPTALDH1A1
SCHEMBL921865 0.94 TRPA1 (0.49) TRPA1SCN5ASCN9AMAPTALDH1A1
Hydrochloric Acid SCHEMBL4599674 0.92 KIF11 (0.55) TRPA1SCN5ASCN9AMAPTALDH1A1
SCHEMBL10435232 0.90 MAOB (0.48) TRPA1SCN5ASCN9AMAPTALDH1A1
SCHEMBL3464539 0.89 TRPA1 (0.46) TRPA1SCN5ASCN9AMAPTALDH1A1
SCHEMBL5470709 0.89 DHODH (0.52) TRPA1SCN5ASCN9AMAPTALDH1A1
SCHEMBL3464533 0.89 TRPA1 (0.46) TRPA1SCN5ASCN9AMAPTALDH1A1
SCHEMBL31739243 0.89 CYP2A6 (0.47) TRPA1SCN5ASCN9AMAPTALDH1A1
SCHEMBL489332 0.86 ENPP2 (0.63) TRPA1SCN5ASCN9AMAPTALDH1A1
SCHEMBL17338824 0.86 EPHX2 (0.51) TRPA1SCN5ASCN9AMAPTALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 266 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113024530-B Isatin-1, 2, 4-oxadiazole compound and preparation method and application thereof 合肥工业大学 2023-07-18 CN claimed
CN-111018780-B N-carbonyl-9, 10-dihydroacridine compound and application thereof 南方医科大学 2022-12-02 CN claimed
CN-113024530-A Isatin-1, 2, 4-oxadiazole compound and preparation method and application thereof 合肥工业大学 2021-06-25 CN claimed
CN-107750250-A Indolone compounds and their use as ampa receptor modulators 詹森药业有限公司 2018-03-02 CN claimed
US-8952083-B2 Fluorocopolymer composition and its production process ASAHI GLASS COMPANY, LIMITED (JP) 2015-02-10 US claimed
WO-2005069000-A2 METHODS OF IDENTIFYING CYTOTOXIC EFFECTS IN QUIESCENT CELLS EISAI CO. LTD. (JP) 2005-07-28 WO claimed
US-4822903-A Fluorinated silica catalyst and preparation of aromatic/aliphatic nitriles in the presence thereof RHONE-POULENC SPECIALITES CHIMIQUES (FR) 1989-04-18 US claimed
US-4438042-A FROM AMIDES, FLUORINATE SILCEOUS CATALYSTS RHONE-POULENC SPECIALITES CHIMIQUES (FR) 1984-03-20 US claimed
US-4436669-A CYANATION, DECARBONYLATION, ACID CATALYSTS RHONE-POULENC SPECIALITES CHIMIQUES (FR) 1984-03-13 US claimed
US-20260001870-A1 INHIBITOR COMPOUNDS Cincera Therapeutics Pty Ltd (AU) 2026-01-01 US disclosed
US-12448371-B2 Inhibitor compounds Cincera Therapeutics Pty Ltd (AU) 2025-10-21 US disclosed
US-20250179008-A1 ANTIBACTERIAL AGENTS TAXIS PHARMACEUTICALS, INC. (US) 2025-06-05 US disclosed
US-20250066370-A1 BICYCLIC TRIAZINE DERIVATIVES FOR THE TREATMENT OF CANCER DEUTSCHES KREBSFORSCH (DE) 2025-02-27 US disclosed
CN-116375602-B Method for photochemically synthesizing benzonitrile by using arylthianthrene salt 河南大学 2024-10-18 CN disclosed
EP-0058424-A2 Pyrazoline derivatives NISSAN CHEMICAL INDUSTRIES LTD. (JP) 1982-08-25 EP disclosed
US-4318866-A Chlorination of 4-methoxybenzoyl chloride ELI LILLY AND COMPANY (US) 1982-03-09 US disclosed
EP-0039157-A1 Chlorination of 4-methoxybenzoyl chloride ELI LILLY AND COMPANY (US) 1981-11-04 EP disclosed
EP-0024888-A2 Ketoximinoether insecticides RHONE-POULENC INC. (US) 1981-03-11 EP disclosed
US-4157344-A REACTING PHENOLS WITH A PERHALOMETHANE AND HYDROGEN FLUORIDE E. I. DU PONT DE NEMOURS AND COMPANY (US) 1979-06-05 US disclosed
US-3994907-A Coumarin derivatives, their preparation and their use as optical brightening agents PRODUITS CHIMIQUES UGINE KUHLMANN (FR) 1976-11-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250066370-A1 BICYCLIC TRIAZINE DERIVATIVES FOR THE TREATMENT OF CANCER BRCA1, CCNY, CCND2 TRPA1 4645/4885SCN5A 1642/4885SCN9A 4793/4885
US-20260001870-A1 INHIBITOR COMPOUNDS CES1, NCEH1, NR1H2 TRPA1 4172/4885SCN5A 1510/4885SCN9A 1536/4885
US-12448371-B2 Inhibitor compounds SERPINB1, MMP1, SSB TRPA1 4787/4885SCN5A 3263/4885SCN9A 4045/4885
US-20250179008-A1 ANTIBACTERIAL AGENTS ALK, ROS1, NOX1 TRPA1 3164/4885SCN5A 1315/4885SCN9A 1697/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.